Chiara Bertossi1, Matteo Cassina2, Luca De Palma1, Marilena Vecchi1, Sara Rossato3, Irene Toldo1, Marta Donà2, Alessandra Murgia1, Clementina Boniver1, Stefano Sartori4. 1. Pediatric Neurology Unit, Department of Women's and Children's Health, University of Padua, Italy. 2. Clinical Genetics Unit, Department of Women's and Children's Health, University of Padua, Italy. 3. Pediatric Unit, City Hospital of Thiene, Italy. 4. Pediatric Neurology Unit, Department of Women's and Children's Health, University of Padua, Italy. Electronic address: stefano.sartori@unipd.it.
Abstract
INTRODUCTION: Duplications of 14q12 encompassing FOXG1 gene have been recently associated with developmental delay, severe speech impairment, epilepsy, aspecific neuroimaging findings and minor dysmorphisms. AIM AND METHODS: In order to refine the epileptic phenotype associated with 14q12 duplications, we have performed a review of the electroclinical picture of the patients reported to date in the literature, adding a new personal case. A comprehensive set of clinical and instrumental data (with a particular focus on the electroclinical aspects including seizure type, age of onset, EEG at onset and after antiepileptic therapy, drug efficacy) has been taken into account. RESULTS: 9/14 patients carrying 14q12 duplications developed seizures, all in the first months of life. Most of them developed infantile spasms (8/9 epileptic patients) and presented hypsarrhythmia or modified hypsarrhythmia on EEG. After therapy 5/9 patients became seizure free and 3/9 present a good seizure control. At last available follow up, 2/3 of the epileptic patients displayed an almost normal EEG, or a quite organized background activity, with diffuse or focal (mostly temporal) slowing. CONCLUSIONS: The review of the available data allowed to recognize a common epileptic core, characterized by early onset, age dependent epileptic encephalopathy with infantile spasms and typical, atypical or modified hypsarrhythmia. Antiepileptic therapy soon led to a good or complete control of seizures with a nearly normal background activity in most patients.
INTRODUCTION: Duplications of 14q12 encompassing FOXG1 gene have been recently associated with developmental delay, severe speech impairment, epilepsy, aspecific neuroimaging findings and minor dysmorphisms. AIM AND METHODS: In order to refine the epileptic phenotype associated with 14q12 duplications, we have performed a review of the electroclinical picture of the patients reported to date in the literature, adding a new personal case. A comprehensive set of clinical and instrumental data (with a particular focus on the electroclinical aspects including seizure type, age of onset, EEG at onset and after antiepileptic therapy, drug efficacy) has been taken into account. RESULTS: 9/14 patients carrying 14q12 duplications developed seizures, all in the first months of life. Most of them developed infantile spasms (8/9 epilepticpatients) and presented hypsarrhythmia or modified hypsarrhythmia on EEG. After therapy 5/9 patients became seizure free and 3/9 present a good seizure control. At last available follow up, 2/3 of the epilepticpatients displayed an almost normal EEG, or a quite organized background activity, with diffuse or focal (mostly temporal) slowing. CONCLUSIONS: The review of the available data allowed to recognize a common epileptic core, characterized by early onset, age dependent epileptic encephalopathy with infantile spasms and typical, atypical or modified hypsarrhythmia. Antiepileptic therapy soon led to a good or complete control of seizures with a nearly normal background activity in most patients.
Authors: Kelly Q McMahon; Apostolos Papandreou; Mandy Ma; Brenda J Barry; Ghayda M Mirzaa; William B Dobyns; Richard H Scott; Natalie Trump; Manju A Kurian; Alex R Paciorkowski Journal: Am J Med Genet A Date: 2015-09-14 Impact factor: 2.802
Authors: Laurie E Seltzer; Mandy Ma; Sohnee Ahmed; Mary Bertrand; William B Dobyns; James Wheless; Alex R Paciorkowski Journal: Epilepsia Date: 2014-05-16 Impact factor: 5.864
Authors: John Hoon Rim; Se Hee Kim; In Sik Hwang; Soon Sung Kwon; Jieun Kim; Hyun Woo Kim; Min Jung Cho; Ara Ko; Song Ee Youn; Jihun Kim; Young Mock Lee; Hee Jung Chung; Joon Soo Lee; Heung Dong Kim; Jong Rak Choi; Seung-Tae Lee; Hoon-Chul Kang Journal: BMC Med Genomics Date: 2018-02-01 Impact factor: 3.063